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Abstract
A potential strategy to combat obesity and its associated complications involves modifying gene expression in adi-
pose cells to reduce lipid accumulation. The nuclear receptor Peroxisome Proliferator-activated receptor gamma
(PPAR)isthemasterregulatorofadiposecelldifferentiationanditsfunctionalactivationiscurrentlyusedasathera-
peutic approach for Diabetes Mellitus type 2. However, total activation of PPAR induces undesirable secondary ef-
fects that might be set with a partial activation. A group of proteins that produce histone demethylation has been
shown to modify the transcriptional activity of nuclear receptors. Here we describe the repressive action of the
jumonji domain containing 2C/lysine demethylase 4 C (JMJD2C/KDM4C) on PPAR transcriptional activation.
JMJD2C significantly reduced the rosiglitazone stimulated PPAR activation. This effect was mainly observed in ex-
periments performed using the Tudor domains that may interact with histone deacetylase class 1 (HDAC) and this in-
teraction probably reduces the mediated activation of PPAR. Trichostatin A, a HDAC inhibitor, reduces the
repressive effect of JMJD2C. When JMJD2C was over-expressed in 3T3-L1 cells, a reduction of differentiation was
observed with the Tudor domain. In summary, we herein describe JMJD2C-mediated reduction of PPARgamma
transcriptional activation as well as preadipocyte differentiation. This novel action of JMJD2C might have an impor-
tant role in new therapeutic approaches to treat obesity and its complications.
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Introduction
Obesity is a public health problem in many countries
because it increases the prevalence of cardiovascular dis-
eases and other metabolic disorders. Secretions from adi-
pocyte cells include a variety of proteins that affect other
organs and can cause complications (Kim et al., 2007).
Transcriptional regulation of some adipocyte genes has
been proposed as a therapeutic option in order to reduce
complications in the obese patient. PPAR is a ligand-
activated transcription factor that belongs to the nuclear
hormone receptor superfamily (Berger et al., 2005).It in-
duces adipose differentiation, modulates the expression of
many adipocyte genes and increases insulin sensitivity
(Leherke and Lazar, 2005). PPAR may bind, as a hetero-
dimerwithretinoicXreceptors(RXRs),tothepromotersof
different genes and regulate glucose and lipid metabolisms
(Desvergne and Wahli, 1999). However, some total
agonists of PPAR such as Rosiglitazone or Pioglitazone
may induce secondary effects such as weight gain, cardiac
alterations and liquid retention in diabetic patients (Semple
et al., 2006; Nissen and Wolski., 2007). To avoid these
complications, new molecules that can selectively modu-
late PPAR transcriptional activity as partial agonists or
partial antagonists are under evaluation (Gelman et al.,
2007).
Recently, a new family of histone demethylase pro-
teinsJMJD2/KDM4(Nottkeetal.,2009),havebeenshown
to modulate the transcriptional activity of some nuclear re-
ceptors (Tan et al., 2008; Wissmann et al., 2007). The
jmjd2-a,- b and -c genes encode proteins containing a JmjC
domain, a JmjN domain, a plant homeodomain (PHD) and
a Tudor domain. The JmjC domain is a putative enzymatic
domain that has been implicated in the regulation of chro-
matin reorganization (Chen et al., 2006). PHD finger mo-
tifs are found in nuclear proteins that participate in chro-
matin-mediated transcriptional regulation and they are
present in a number of oncogenes (Yang et al., 2001). The
doubleTudordomainhasaninterdigitatedstructure,andan
unusual fold is required for it to bind methylated histone
tails(Huangetal.,2006).BoththeJmjNandJmjCdomains
are required for demethylase activity, while the PHD and
Tudor domains are required for interactions with other pro-
teins and bipartite nuclear and cytoplasmic localization
(Whetstine et al., 2006).
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Research ArticleWe have shown that JMJD2A associates with mem-
bers of the class I HDAC’s transcriptional repressor pro-
teins and that amino acids 661-1064 of JMJD2A, which
contains the PHD and Tudor domains, was the minimum
regionnecessarytoassociatedirectrepression,possiblybe-
cause of its ability to recruit both pRb and HDACs proteins
andrepresstheexpressionofsomecellcyclegenes(Grayet
al., 2005).
However, the influence of these proteins on trans-
criptional activity is variable. Recently, it was shown that
JMJD2A,JMJD2CandJMJD2Dmayactivateandrogenre-
ceptors(AR),glucocorticoidreceptors(GR)andprogester-
one receptors (PR) in the presence of ligands, but these
effects were probably due to histone 3 lysine 9 trimethylate
(H3K9me3) demethylation mediated by the JmjC domain
(Wissmann et al., 2007; Shin and Janknecht, 2007). How-
ever, there is no clear evidence concerning the influence of
JMJD2 proteins on nuclear receptors that heterodimerize
with RXR, these proteins have been shown to be clinically
relevant for endocrine disorders, cancer, metabolic syn-
dromes and type 2 diabetes (Shulman and Mangelsdorf,
2005). In the present work, we show that JMJD2C may re-
duce PPAR ligand transcriptional activity for
PPARgamma response element (PPRE) genes and that this
activity is mainly mediated by the Tudor domain probably
through the binding of HDAC class I repressors. JMJD2C
mayalsoreducepre-adipocyte3T3L-1celldifferentiation.
Materials and Methods
Plasmids and Vectors
Plasmids containing the full-length JMJD2C cDNA,
as well as each individual domain, were constructed. The
full-length JMJD2C cDNA (KIAA0780) was obtained
from the Kazusa Institute, Japan. Primers were selected us-
ing the software Amplify 3X. The sequences were com-
pared with other sequences from GenBank, using the
BLAST program and primers with homology to different
sequences were redesigned. All primers were purchased
from Invitrogen: JMJD2C-fwd: 5’-TAGCGGCCGCATG
GAGGTGG-3’, JMJD2C-rvs: GCTCTAGATAGGTTCC
ACTAAG-3’, JmjC- fwd:5’-CACCATGACTG TGAAG
GAGTTC-3’, JmjC-rvs:5’-CCTGCAAGTGCACAATTT
GGC-3’, Tudor-fwd: 5’CACCATGGCTGTGACATC
GCA-3’, Tudor-rvs:5’-ATAGGTTCCACTAAGGAAAA
TG-3’. Each domain was amplified by protein chain reac-
tion (PCR), purified in a 2% agarose gel and cloned into
pcDNA3.1vectorusingaDirectionalTOPOExpressionkit
(Invitrogen, USA). The PPRE and PPAR expression plas-
midswereagiftformDr.BruceSpiegelman(DananFarber
Institute) and Peter Tontonoz (UCLA). PPRE-LUC is a
-5.4 kb to -4.9 adipocyte P2 gene (aP2) enhancer (518-bp
DNA fragment) binding to luciferase.
Transient transfections and luciferase assays
Assays were performed in the U2OS and 293 cell
lines obtained from American Tissue Culture Collection
(ATCC). These were grown in Dulbecco’s modified Ea-
gle’s medium (DMEM) with 10% of fetal bovine serum
(FBS)and100U/mLpenicillin/100g/mLstreptomycinin
a5 %C O 2 atmosphere. When cells were 85% confluent,
theyweretransientlytransfectedusingLipofectamine2000
(Invitrogen, USA). The cells were co-transfected with ei-
ther reporter plasmids (0.85 g/well) containing the
PPRE-LUC and pSVSport-PPAR (0.2 g/well), or re-
porter plasmids 5x-UAS-LUC (0.85 ug/well) and Gal4-
PPAR (0.2 g/well), Cells were also transfected with a
plasmid encoding JMJD2C, JMJD2C-JmjC or JMJD2C-
Tudor. Rosiglitazone 1  M (GlaxoSmithKline, UK) was
used as the ligand, and assays were also performed with a
histone deacetylase (HDAC) inhibitor, Trichostatin A
100 nM (Sigma, USA). Luciferase assays were performed
using a Luminometer Lumat LB 9507 (Berthold Technol-
ogies, Germany). Values were normalized to -galacto-
sidase activity and the data are shown as the mean  S.E.
from a minimum of three independent experiments, with
each sample being run in triplicate.
RNA interference
3T3-L1 cell lines were obtained from American Tis-
sue Culture Collection (ATCC) and transfected with dou-
ble-stranded oligonucleotides targeting JMJD2C (Invitro-
gen, USA) in order to select the oligos and the
concentration that most efficiently silenced JMJD2C ex-
pression. Three sets of oligos were assayed, and we used
thesiRNAAUUUGUUGAACUCCCGGAACUCCUC
at 100 nM concentration for experiments reported here.
3T3-L1 cells were induced to differentiate and were
transfected after the fourth day with this duplex. RT-PCR
was used to confirm the silencing of JMJD2C.
Adipocyte differentiation
3T3-L1 preadipocytes were grown in DMEM me-
dium containing 10% FBS. Cells were transiently trans-
fected with a plasmid expressing JMJD2C, JmjC or Tudor
using Lipofectamine 2000 (Invitrogen, USA). Two days
after the cells reached 100% confluence, they were incu-
bated in DMEM containing a differentiation cocktail
(1 M dexamethasone, 0.5 mM 3-isobutyl-1-methyl-
xanthine(IBMX)and1MRosiglitazone),and48hlater,
the cells were treated with 1 M Rosiglitazone. After
8 days of differentiation, cells were fixed with formalde-
hyde and stained with Oil Red O, which binds to triacyl-
glycerol (TAG) in fat droplets, a hallmark of adipocyte
formation, for 2 h. Cells were then washed with ddH2O
and staining was analyzed in a biophotometer (Eppendorf
AG, Germany) at 520 nm.
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Cultured 3T3L-1 cells were lysed in RIPA buffer (1x
PBS, 1% Nonidet P-40, 0.1% SDS) and protease inhibitor
complex (Roche, Germany). After centrifugation, 10 go f
total protein from the supernatant was mixed with an equal
volume of sample buffer and denatured at 95 °C for 4 min.
Electrophoresis was done in an 8% SDS-polyacrylamide
gel, followed by transfer to a nitrocellulose filter by tank
blotting with transfer buffer pH 8.3 (39 mM glycine,
48mMTrisbase,0.037%SDS,20%methanol.Aftertrans-
fer, the membrane was incubated with 5% non-fat dried
milk, in 0.1% (v/v). Tween 20 in PBS (PBS-T) for1ha t
room temperature to block the unspecific binding sites. Af-
ter washing, the membrane was incubated with a rabbit
anti-JMJD2C (SH-18) antibody (1:500 dilution; Abcam
ab27532, USA). Following four washes with PBS-T and
incubation with HRP-conjugated anti-rabbit IgG (1:2000
dilution;Amersham,UK)for1h,themembranewasdevel-
oped using ECL solution (Amersham, UK). The reaction
was visualized with autoradiography film according to the
manufacturer’s instructions (Hyperfilm ECL, Amersham,
UK).
Immunoprecipitation
At 36 h post transfection, U2Os cells were washed
with PBS and harvested in lysis buffer containing protease
inhibitors. Proteins were immunoprecipitated from the
supernatant by overnight incubation with an anti-HDAC1
or anti-HDAC3 antibody (Affinity Bioreagents, USA) at
4 °C. The immunoprecipitated proteins were precipitated
using protein A-agarose and analyzed using 8%
SDS-PAGE. Additionally, 3T3-L1 preadipocytes were dif-
ferentiated as described previously and the cells were
washed with PBS and harvested on days 0, 4 and 8 in lysis
buffer containing protease inhibitors. Whole-cell lysates
were incubated with a PPAR-specific antibody for 2 h at
4 °C, and the proteins recovered by using protein A-sepha-
rose (Invitrogen, USA) for 2 h at 4 °C. The recovered pro-
teins were washed three times with 1% Triton X-100 in
PBSandanalyzedinwesternblotswithaJMJD2C-specific
antibody.
RT-PCR analysis
Total RNA was isolated from cultured 3T3-L1 cells,
using a (Qiagen, USA) kit. Reverse transcription was car-
riedoutat37°Cfor90minandstoppedat75°Cfor10min.
PCR was carried out using 1 L of the RT reaction, 10x re-
action buffer (200 mM Tris-HCL, 500 mM KCL), 50 mM
MgCl2,10mMdNTP’s,50pMoftheprimerpairand7Uof
Taq DNA polymerase (Invitrogen, USA) in a total volume
of 100 L. PCR was performed with the primers specific
for the JmjC domain of JMJD2C. The PCR products were
analyzed in a 1% agarose gel. The size of the amplicon was
650 bp, which matched the expected size.
Results
JMJD2C-mediated repression of PPAR
transcriptional activity
In transient transfection studies with PPRE and
5XUAS reporter constructs we observed that JMJD2C par-
tiallyreducedPPARligand-dependenttransactivationfol-
lowing treatment with Rosiglitazone (Figure 1A). When
the Tudor domain was assayed, we found that this domain
reduced PPAR transactivation activity (Figure 1A). Con-
versely, when the JmjC domain was studied, a significant
increase of PPAR activity was observed (Figure1A). To
further investigate the relationship between JMJD2C and
PPAR, we performed RT-PCR and western blot analyses
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Figure1-JMJD2CpartiallyrepressesPPARtranscriptionalactivity.(A)PPARtranscriptionalactivityfollowingexpressionofJMJD2C,orofeachof
its domains, in both the absence and presence of Rosiglitazone (1 M).
*p < 0.05. (B) PPAR transcriptional activity after transfection with expression
vectors with JMJD2C or the JmjC and Tudor domains. *p < 0.05, in presence and absence of TSA (100 nM) for each case. U2Os cells were transfected
with constructs expressing each domain, and luciferase reactive activity was measured and normalized with -galactosidase activity. The values are pre-
sented as means  S.E. from at least two independent triplicate assays.to investigate how JMJD2C is expressed in the preadi-
pocytes 3T3-L1 cell lines. JMJD2C was continuously ex-
pressed during differentiation of 3T3-L1 cells with dexa-
methasone, isobutyl-metylxanthine and Rosiglitazone
(Figure 2).
JMJD2C binds histone deacetylases
We had previously observed that JMJD2A-mediated
repressor activity was associated with pRb and histone
deacetylases, and that it increases the pRb-mediated-
repression on E2F-regulated promoters (Gray et al., 2005).
InordertodetermineifJMJD2Crepressoractivityisdueto
binding with HDACs, functional assays were performed
following transient transfection with the Gal4-PPAR and
UAS-LUC reporters and Rosiglitazone treatment. When
adding Trichostatin A, an inhibitor of HDACS, the repres-
sive activity of JMJD2C and the Tudor Domain were
blocked (Figure 1B). These results suggest that JMJD2C
repression activity is mediated through the binding to
HDACs, which are important in the assembly of the trans-
criptional repression complex. Conversely, the JmjC medi-
ated activation of PPAR was reduced when TSA was
added. This demonstrates that TSA probably reduces the
capacity of the JmjC domain to activate the transcription of
genes regulated by PPAR (Figure 1B). In order to check if
JMJD2CcouldbindtoHDACs,immunoprecipitationstud-
ieswereperformed.WeobservedthatJMJD2Cmaybindto
HDAC1 and HDAC3 (Figure 2A), besides binding with
PPAR during the differentiation process (Figure 2B).
These observations highlight the importance of JMJD2C
on the transcriptional activity of PPAR.
Effect of JMJD2C on 3T3-L1 pre-adipocyte
differentiation
We induced cell differentiation in 3T3-L1 pre-adi-
pocytes expressing JMJD2C or the JmJC and Tudor do-
mains. The fat storage capacity of the differentiated adi-
pocytes was reduced when the JMJD2C or Tudor domains
were over-expressed. We observed the same effect as ob-
served with the transient transfections, except with JmjC
(Figure3A),whichdidnotshowanysignificantdifferences
(Figure 3B).
Weobservedamodestincreaseinadipocytedifferen-
tiation (Figure 4A) and Red Oil O staining (Figure 4B)
when JMJD2C was down-regulated using RNAi compared
to the control.
Discussion
In the present work we demonstrate that JMJD2C
mayrepresstheactivityofPPARgammaandreducetheac-
cumulation of triglycerides in adipocyte cells. The repres-
sive effect on PPARgamma-mediated activation is due to
the binding of JMJD2C to histone deacetylase repressors.
In fact, the transfection studies showed that JMJD2C pro-
tein and the Tudor domains significantly reduced
PPARgamma activation in the presence of the ligand.
When Trichostatin A, an inhibitor of HDAC, was added in
theseexperiments,therepressiveeffectofJMJD2Candthe
Tudor domain was attenuated.
We previously observed that the homologous protein
JMJD2A could repress gene expression due to binding to
HDACproteins.Theseobservationssupportthosereported
by Kim et al. (2006), who proposed that JMJD2C has
repressor activity and that Tudor domains are required for
this action. This repression may be due to the capacity of
Tudor domains to bind to histone tails (Huang et al., 2006;
22 Lizcano et al.
Figure2-JMJD2Cexpressioninthe3T3-L1cellline,capacityofbinding
tohistonedeacetylasesand–toPPAR(A)RNAextractionsandRT-PCR
assays for JMJD2c were performed on 3T3-L1 cell line at days 0, 4 and 8
of differentiation; (B) Western blot showing JMJD2C expression at all
days of differentiation; (C) Co-immunoprecipitation of JMJD2C and
HDAC type I.
Figure 3 - Effect of JMJD2C over-expression on 3T3-L1 pre-adipocyte
differentiation.(A)Micrographsof3T3-L1cellsaftereightdaysofdiffer-
entiation, following over-expression of JMJD2C or the JmjC and Tudor
domains. Transfections were performed on day 0, when confluence of
pre-adipocytes was 100%; (B) Triglyceride levels in differentiated 3T3-
L1 cells. Values are presented as the means  S.E. from at least two inde-
pendent assays, each run in triplicate.Lee et al., 2008; Rottach et al., 2010). The Tudor domains
of JMJD2A bind to methylated histones (H3K4 and
H4K20) and the extent of the methylation, along with the
presence of the enzymes Suv39h, is important for the inter-
action (mono- di- and trimethylation) (Kim et al., 2006).
Zhang et al. (2005) observed an interaction between
JMJD2A and NCoR, and proposed that the C-terminal re-
gioncontainingtheTudordomainshasconsistentrepressor
activity, while the JmjC and JmjN domains do not.
In our study when the JmjC domain was evaluated, a
significant increase in PPAR activity was observed (Fig-
ure 1A). JmjC is a catalytic domain that is involved in the
regulation of chromatin reorganization processes through
heterochromatization modulation (Ayoub et al., 2003) and
it has been shown that JmjC demethylates lysine residues
that are di- or tri-methylated on histone 3 and 4 tails (Tsu-
kada et al., 2006). Furthermore, its amino acid sequences is
conserved and it is related with the binding between Fe
+2
and -ketoglutarate, which are required for the demethyl-
aseactivityofproteinsthatcontainthisdomain(Tsukadaet
al., 2006).
Recently, JMJD2C has been described as a co-
activator of certain nuclear receptors, such as androgen re-
ceptors(AR),glucocorticoidreceptors(GR)andprogester-
one receptors (PR), and this effect may explain, in part, its
demethylaseactivityontri-methylH3K9(Wissmannetal.,
2007). Nevertheless, PPAR belongs to a different family
of the nuclear receptor superfamily of transcription factors;
it groups together with thyroid hormone receptor (TR),
retinoic acid receptor (RAR) and Vitamin D receptor
(VDR)thatbindtoDNAasheterodimerswith9-cis-reinoic
acid receptor (RXR) and form a complex with the co-
repressors NCoR and SMRT (Wu and Zhang, 2009).
JMJD2A is part of the NCoR repressor complex and might
have a role in receptor-mediated transcriptional repression
(Zhang et al., 2005). Interestingly, JMJD2A is implicated
in epigenetic regulation of the achaete-scute complex
homolog 2 (ASCL2), a basic helix-loop-helix transcription
factor whose mouse homolog is encoded by an imprinted
gene that is highly expressed during development of ex-
tra-embryonic trophoblast lineages, but repressed in other
tissues. It is essential for proper placental development, a
process regulated by steroid hormones and their receptors
(Zhang et al., 2005).
Consequently, we consider that different domains
may have different roles, and that the catalytic domain
JmjC is probably not involved in the JMJD2C-mediated
negative regulation of PPAR observed herein. To further
investigate the relationship between JMJD2C and PPAR,
we performed RT-PCR and western blot analyses to check
how JMJD2C is expressed in the preadipocytes 3T3-L1cell
line. JMJD2C was continuously expressed during differen-
tiation of 3T3-L1 cells exposed to dexamethasone, iso-
butyl-metylxanthine and Rosiglitazone (Figure 2).
The fat storage capacity of the differentiated adi-
pocytes was reduced when the JMJD2C or Tudor domains
were over-expressed. We also observed a modest increase
in adipocyte differentiation (Figure 4A) or Red Oil O stain-
ing (Figure 4B) when JMJD2C was down-regulated by
means of RNAi. Recent knockout studies on Jhdm2a
(Jumonji protein also known as KDM3A) deficient mice
resultedinobesityphenotypesthatmaybeinpartexplained
by a reduced -adrenergic receptor and PPAR activity
(Tateishi et al., 2009).
The relation between histone deacetylation and
demethylation has been reported previously (Lee et al.,
2006) with the demethylase protein LSD1 (KDM1A),
which is part of a repressor complex that include deace-
thylase proteins. This observation is related with the activ-
ity of JMJD2C that we observed in the present work.
PPARtranscriptionalactivityreducedbyJMJD2Cwasre-
covered when TSA was added, suggesting that a similar
level of PPAR activity was retained only in presence of its
ligand,andthathyperacetylationscenariooccursinthepro-
moter region of PPAR. When JMJD2C was inhibited by
RNAi or by blocking its repressor activity with TSA, an in-
creased level of PPAR transcriptional activity was ob-
served, measured either in the transfections or by menas of
the adipocyte differentiation assay. This suggests that the
absence of JMJD2C might slightly influence the fat storage
in adipocytes, while its over-expression results in a partial
reduction of PPAR transcriptional activity. Thus,
JMJD2C may modulate the differentiation of adipose cells
and reduce lipid accumulation. Our results indicate that
JMJD2CmaybedescribedasaselectivePPARmodulator
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Figure 4 - Results of RNAi-mediated silencing of JMJD2C. (A) Micro-
graphs of 3T3-L1 after eight days of differentiation; (B) Triglyceride lev-
elsindifferentiated3T3-L1cellsfollowingtransfectionwithspecificcon-
structs. The negative control was not induced to differentiate, whereas the
positivecontrolwasmock-transfectedandinducedtodifferentiate.Values
are presented as the means  S.E. from at least two independent assays,
each run in triplicate; (C) RT-PCR results showing JMJD2C transcript
levels for the different treatments at 48 h after transfection.(SPARMS). This class of molecules has the ability of regu-
lating the PPAR receptor activity more selectively, possi-
bly through differential co-repressor and co-activator
recruitment (Sugii et al., 2009). This could have a benefi-
cial effect, by avoiding weight gain, improving insulin sen-
sitivity, and reducing liquid accumulation.
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